Select Committee on Science and Technology Minutes of Evidence


Examination of Witnesses (Questions 1-19)

CAROLINE FLINT MP, MR HUGH WHITTALL AND MR TED WEBB

12 JULY 2006

  Q1 Chairman: Could I welcome Minister Caroline Flint and indeed your colleagues, who you will introduce yourself, Minister. This is an opportunity to follow up the former Committee's report on human reproductive technologies and the law, and indeed the consultation that was put in train during the production of that report and the government's response, and indeed to try and follow on with some of the issues that were raised during the debate last Monday on the floor of the House and the Estimates Day as well. We are very grateful to you, Minister, for coming. Can we call you Caroline?

  Caroline Flint: That is perfectly all right, Phil!

  Q2 Chairman: Could you introduce your colleagues to us?

  Caroline Flint: This is Hugh Whittall, who is the branch head of the Human Tissue Branch, which is part of our scientific development in the bioethics division; and this is Ted Webb, who is section head of Assisted Reproduction Policy area within the same division, and hopefully they will be able to support me this morning where I will need it.

  Q3  Chairman: Thank you very much and welcome to you both. Could I say that this session is being televised so if you could be careful not to use any unacceptable language, as they say in the Big Brother house! Caroline, the government was rightly consulted widely on updating the HFE Act and has taken time to consider the options, but how close are you now to bringing your thoughts and firm proposals to the House?

  Caroline Flint: It has been a very interesting exercise for myself, obviously, as when I became Public Health Minister and had responsibility for this area our consultation was already building on the work that this Committee had done, and I think considerable discussion amongst the public and those bodies involved, the HFEA in particular, and other organisations as well about taking stock of where we are in terms of development since the legislation first came into being. We have had a huge number of responses. You will not be surprised to know that a number of those responses were from individuals who have a particular view and concern in this matter, but also I think we had a broad range of organisations too. I think where we are at the moment is that we feel that we are making progress in determining some of our views about the way forward, and in fact I think we tried to indicate in the consultation papers some of the areas where we felt we intended to go.

  Q4  Chairman: Are we going to get a Bill or a White Paper?

  Caroline Flint: What I am hoping to do is to announce some more definite proposals later this year.

  Q5  Chairman: What does "later this year" mean?

  Caroline Flint: Hopefully over the summer period I will be making some announcements. But at the moment I cannot at this point say in terms of a Bill because that is a matter in terms of discussion within the legislative cycle, but what I can say to you—and I said this last week in the debate—is I think that the process we have been through has been important in engaging people in debate, and I am looking at ways in which we continue that exploration because I do think it is important to this particular area that we achieve, as much as is possible, a consensus on the way forward, and I think that that can be informed by greater scrutiny and parliamentary involvement; so that is something I am giving very serious consideration to at the moment.

  Q6  Chairman: So you are expecting over the summer to produce some draft proposals either for a Bill or a White Paper with a timetable to that. By Christmas do we expect to have firm proposals as to what in fact you are going to do about amalgamating the Human Tissue Authority and also HFEA?

  Caroline Flint: What I can say about that particular issue is that we do intend to move ahead to amalgamate those two organisations and we are very clear about that. Already we are seeing joint work between the two organisations in looking at back room functions and how they work together, so that is the direction for which we are on course. What I can say to you is, yes, I definitely would hope that by Christmas, or even before, that we would have some firm proposals that would be part of the ongoing debate.

  Q7  Chairman: Your main proposals will actually come out during the recess.

  Caroline Flint: What I am saying is that over the next few months, which obviously is the summer, there may be some particular policy points that I will be looking to make some announcements on.

  Q8  Chairman: In terms of pre-legislative scrutiny is there an opportunity, do you think, for this Committee, which has taken a very keen interest in this area, to be involved in that process? Is that in your thinking?

  Caroline Flint: I do consider that scrutiny is going to be important in this and it is one of the areas I am considering in relation to how we develop the debate. I think that the process so far has been very positive and I think it is quite important to have the debate because—and you can see that from the debate we had last week—possibly sometimes if it is too truncated some of the issues that deserve some attention do not get the attention that they deserve against some of the more headline issues within this area. So that is something to which I am giving consideration, about the opportunities for parliamentary scrutiny and further discussion, and that obviously would involve this Committee too.

  Q9  Chairman: I just think, Minister, that there would be some disquiet if in fact major proposals came out during the recess without the opportunity for Parliament to be able to immediately respond to those. Is that not a concern?

  Caroline Flint: I think it would be a direction of the way we are going; it is not the end of the discussion, it is the direction we are going. What people have asked me for and asked our department for are clearer indications of our views. This morning I am sure you are going to ask me some questions on particular issues and in some areas I hope I am going to be able to give you a helpful guide to the government's thinking in some of these areas. But, as I have said, whatever I say today or whatever I might say during the summer, I think there is plenty of room for more discussion and scrutiny of those issues, but I think it is important that people have an understanding about the direction of the debate and where it is going. So it is not about shutting down debate but it is about giving a clear indication of that which the debate can form around.

  Q10  Chairman: With respect, Minister, this has been going on for an awful long time.

  Caroline Flint: Yes, but I do not think that in itself is a bad thing. I think the previous inquiries into different areas that have raised similar issues, both in terms of the science and also the ethics and principles that this area develops, also have had considerable amounts of time to debate these issues and take these issues forward. I have to say that one of the points that came out of the consultation and the discussions that we had with the different interests in this area has been a view that it is better to get it right than to speed into a process. This may seem a long process but actually I think our chance to change the legislation—and considering that the legislation has been pretty good for the time we have had it—is a serious one, and there are not that many opportunities that come around for that. We also have to think in terms of the legislation what parameters we need to have to cover future changes that we may not know about at the moment or are only just beginning. So I think it is quite a complex area to come through with something that can define certain areas that are practised already in a way that are not covered by the present legislation—and I am sure we will come on to those issues—but at the same time try to create a piece of legislation that has the flexibility in it to deal with changes with science, but that are also mindful of ethical concerns too. So I do not think that the time in itself is a bad thing and I do not think that the time is prejudicing, in any particular way, the functioning of the Act as it is at the moment.

  Q11  Chairman: In terms of the consultation, did you learn anything from the consultation that you did not know already?

  Caroline Flint: Interestingly—and we may come on to this, it came up in the debate last week—the issue around the welfare of the child. Before the consultation the view I was getting was that within the organised professions, the medical groups and others, was that there was a desire for this to be removed. Actually our consultation indicated that amongst the medical organisations, whilst they felt that there were some issues around it they thought that there should still be a need for that to be retained. So that is certainly one thing that came out of that process. But, again, part of it is about recognising—and I think you can see from the document that we have produced in relation to the consultation process—that there are a varied number of views and there is not necessarily a consensus amongst different groups on the issues and therefore we still have to take that on board and at the same time think about the way ahead.

  Q12  Chairman: But with respect, the consultation, which was responded to by a self-selecting group of people or organisations, there was no methodology towards an analysis of the responses; there was no weighting to different responses, so I do not see what that has done in terms of bringing government thinking forward.

  Caroline Flint: We had 535 formal responses, we had submissions—

  Q13  Chairman: I am not debating the number of responses—

  Caroline Flint: Submissions from around 100 organisations and of course we look at these and we look at organisations. Yes, as with any consultation that government undertakes, you can have a situation where individuals respond because they represent a particular point of view, and we do take some of that into account and we will be thinking about that in relation to how we make our considered view on what should be the policy direction; that is what consultations do, they hopefully create input from the organisations that are most involved, those who in the end have to implement the law, those who have to practise under the law and other organisations that have an interest in this area. But, undoubtedly, as with any consultation, this particular area does create a large number of responses of individuals who have a particular, often moral point of view about this science and this area of work.

  Q14  Chairman: And we saw that in the debate last week, but surely the job of government in fact is not to look at where the public opinion is running, but in fact to create a regulatory framework that is based on good, strong scientific and ethical bases.

  Caroline Flint: Absolutely.

  Q15  Chairman: What we do not seem to be getting is any sort of clear steer from you in terms of where that ethical direction is going to come from: is it going to come from government, is it going to come from Parliament as a whole? And in terms of the scientific framework the consultation document, I am arguing, did not take you any further forward than you were in August of last year when you actually began the consultation process.

  Caroline Flint: I think that is unfair because I think consultation plays a lot of roles. Firstly, it is, you are right in saying, to possibly inform us of views that we had not thought about and to consider evidence that maybe we had not given enough weight to, but part of it again is about testing the views and certainly in the consultation document we produced in some areas we were asking questions that were in many respects looking for confirmation of some of the directions we wanted to take. In a number of areas we have already publicly agreed with some of the recommendations made by this Committee in their report, but, again, as I said, we are working through not just the responses to the consultation but the difficult areas in both the science and in terms of the ethics to try and come forward with something that we hope will not only get the support of Parliament, but also be a piece of legislation that is both clear in the areas it needs to be clear but also flexible in order that as changes develop action can be taken. Part of that process is the way in which we are trying to think about Parliament's role in some of these areas and, for example, what more might need to be included in legislation, which currently is not, and I think that is an issue that we have been trying to go through in the best way.

  Q16  Chairman: Before I pass you on to Des, could I ask you for a straight answer—all your answers are straight, I did not mean that in that sense, Caroline—in terms of the role of Parliament in determining the ethical framework: do you think that is the job of Parliament or is it the job of government?

  Caroline Flint: I think it is the job of Parliament to have a very important role in that and that is one of the areas we are considering. There are a number of issues—and I do not want to pre-empt too many questions—that were raised in last week's debate and probably will be asked today, where we are considering the right balance between the regulator making these decisions or Parliament having an input in these decisions as well, and the right way to go about that in terms of the issues that should be either on the face of the Bill or there should be secondary powers, or whatever, or regulatory powers. And these are complex issues. I do think, at the same time though, that there does not appear to be enough scope for the regulator to also deal with some of these changes as well, and I think for the most part the regulators work well in these areas.

  Q17  Dr Turner: You rightly say that it has worked well up to now but it has increasingly in recent years started to run into difficulty in quite difficult areas, some of which are still snarled up in the courts, which is not a good thing, which is one of the motivations in our recommendations to take away from the HFEA or its successor body, RATE, some of these acute policy making decisions. And that is a journey you are familiar with—RATE, as it has obviously been called, and the Bioethics Commission Standing Committee in Parliament. You clearly seem to wish to continue with in principle the model which we currently have, is that correct?

  Caroline Flint: I think that is correct. We did consider the question of the Bioethics Commission and, as I say, having a remit to cover the entirety of bioethic issues as part of our review of arm's length bodies, and it was something that was given consideration. I think it was felt that the present model of a number of advisory bodies that have a role to play in this area was better because it allowed more specific experience and knowledge to be brought to bear on a range of different issues, and it was felt that just one Commission in itself may not be able to develop dedicated groups in expertise and sufficient time to devote to a wider range of issues. That was one of the reasons, and the main reason why we did not think that was necessary. In terms of the idea of the Parliamentary Standing Committee on bioethics, that really is a matter for Parliament rather than government, but of course you would then have to think about how this Committee and other Committees would work either in parallel or jointly with that Committee as well, but that is a matter, I think, for Parliament to decide. As I have indicated, some of the areas that we are exploring and giving some consideration to is in what ways Parliament, through the legislation, can be clearer about some of these issues where developments emerge but also in what ways Parliament can have more of a say when science changes, when issues come to the fore that maybe are not here at the present, but may become an issue later on.

  Q18  Dr Turner: This is coming very close to one of the central constitutional issues, is it not, because we have a Parliament that contains within it the Executive and in this particular instance the legislation which governs the area is traditionally by free vote which really makes Parliament the supreme voice in this, would you not agree?

  Caroline Flint: I think this is one of the areas where Parliament does have to take an important role and that is why it has been very important the last time round to get the support of Parliament for the legislation as it stands. I have to say that, yes, there have been some issues where the HFEA has had to deal with some matters and debates about whether it has the power or it does not have the power and sometimes that has, as you quite rightly say, ended up in the court. But all told I think it has been a pretty robust system and I have to say that other countries around the world look to the way we have regulated as an example of something that is a good model to follow, and I think that should be recognised.

  Q19  Dr Turner: Absolutely.

  Caroline Flint: But that does not mean that there are not issues that have happened over the intervening years; that actually in many respects the HFEA in its submission has made comment of where it would like some clarity in terms of its own responsibilities and, as I say, this is something we are thinking about and trying to think about the best way forward in terms of hopefully a piece of legislation that will stand the test of time that the current one has.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2006
Prepared 1 November 2006